Celcuity (CELC) Change in Account Payables (2016 - 2025)
Celcuity (CELC) reported Change in Account Payables of -$4.8 million for Q4 2025, down 2273.42% on a YoY basis from $222000.0 in Q4 2024, and down 8672.73% quarter-over-quarter from -$55000.0 in Q3 2025.
Celcuity (CELC) Change in Account Payables (2016 - 2025) Analysis & Trends
Celcuity has reported Change in Account Payables for 10 years, with the latest figure at -$4.8 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 2273.42% year-over-year to -$4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$3.0 million (down 170.44% YoY), and the FY2025 full-year result was -$3.0 million, down 170.44% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$4.8 million, down from -$55000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $2.9 million in Q3 2024, with the low at -$4.8 million in Q4 2025.
- Historically, Change in Account Payables has averaged $304481.3 across 5 years, with a median of $301047.0 in 2021.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 19904.03% — and 2025, when it plunged 2273.42%.
- Celcuity's Change in Account Payables stood at -$247449.0 in 2021, then plunged by 92.4% to -$476096.0 in 2022, then fell by 26.3% to -$601309.0 in 2023, then soared by 136.92% to $222000.0 in 2024, then sank by 2273.42% to -$4.8 million in 2025.
- The last three Change in Account Payables figures came in at -$4.8 million (Q4 2025), -$55000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | -4.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.83 Mn |
| Dec 31, 2025 | -4.83 Mn |
| Sep 30, 2025 | -55,000.00 |
| Sep 30, 2025 | -55,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 613,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 945,000.00 |
| Jun 30, 2024 | 945,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Dec 31, 2023 | -601,309.00 |
| Dec 31, 2023 | -601,309.00 |
| Sep 30, 2023 | 2.61 Mn |
| Sep 30, 2023 | 2.61 Mn |